Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03938883 · ClinicalTrials.gov registry record · NA
Ocular Bandage Gel (OBG) Pivotal Trial in Patients Undergoing Photorefractive Keratectomy ("PRK")
A NA study, sponsored by Eyegate Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
NCT03938883 is a NA study that has completed, run by Eyegate Pharmaceuticals. The registered enrollment target is 250 participants.
The verdict
NCT03938883, a NA study, has completed, sponsored by Eyegate Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
Study Summary
Prospective, randomized, masked (reading center), controlled pivotal study of Ocular Bandage Gel (OBG) vs. a bandage contact lens (BCL) in subjects who have undergone bilateral photorefractive keratectomy (PRK).
Interventions
- DEVICE Ocular Bandage Gel (OBG)
- DEVICE Bandage Contact Lens (BCL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2019-06-25 |
| Est. Completion | 2019-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03938883
The ClinicalTrials.gov registry entry for NCT03938883 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eyegate Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ocular Bandage Gel (OBG) is the first listed.
NCT03938883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03938883 about?
NCT03938883 is a clinical study titled "Ocular Bandage Gel (OBG) Pivotal Trial in Patients Undergoing Photorefractive Keratectomy ("PRK")". Prospective, randomized, masked (reading center), controlled pivotal study of Ocular Bandage Gel (OBG) vs. a bandage contact lens (BCL) in subjects who have undergone bilateral photorefractive keratectomy (PRK).
What is the current status of trial NCT03938883?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2019-06-25. Estimated completion is 2019-10-10.
What interventions are being tested in trial NCT03938883?
The interventions under investigation include: Ocular Bandage Gel (OBG) (DEVICE), Bandage Contact Lens (BCL) (DEVICE).
Who is sponsoring clinical trial NCT03938883?
This trial is sponsored by Eyegate Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.